HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti-HER-2/neu (4B5)Yoshiya Horimoto,Hiroko Onagi,Junichiro Watanabe,Takuo HayashiPATHOLOGY INTERNATIONAL(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要